Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

F-Prime Capital Partners

F-Prime Capital Partners
VC INVESTOR TYPE
Active STATUS
25 PROFESSIONALS
260 INVESTMENTS
124 PORTFOLIO
69 EXITS
Description

F-Prime Capital Partners is a venture capital firm headquartered in Cambridge, Massachusetts. The firm seeks to make investments in firms focused in biopharmaceutical, medtech, healthcare service, enterprise information technology and fintech.

Formerly Known As
Fidelity Biosciences
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1969
Primary Investor Type
Venture Capital
Primary Office
  • 1 Main Street
  • 13th Floor
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000

F-Prime Capital Partners Investments (260)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Snapsheet 20-May-2019 Later Stage VC 0000 Automotive Insurance Generating Revenue 00000000 00000
00000 000000000000 07-May-2019 00000 00000 000.00 Drug Discovery Startup 0000000 000000 00.0
0000000 02-May-2019 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue
000000 00000000000 18-Apr-2019 00000 00000 0000 Drug Discovery Startup
000000 10-Apr-2019 00000 00000 000.00 Monitoring Equipment Generating Revenue 0000 00000
000 0000000000 08-Apr-2019 00000 00000 0000 Therapeutic Devices Product Development 00000 00000 00
00000000 07-Apr-2019 00000 00000 000.00 Network Management Software Generating Revenue 000000 0000
00000000 02-Apr-2019 00000 00000 0000 Other Financial Services Generating Revenue 00000000 00000
Kyruus 15-Mar-2019 Later Stage VC 0000 Information Services (B2C) Generating Revenue
Artemis Health 14-Mar-2019 Later Stage VC 0000 Other Healthcare Technology Systems Generating Revenue 00000000 000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore F-Prime Capital Partners’s full profile, request a free trial.

F-Prime Capital Partners Exits (69)

Company Name Exit Date Exit Type Exit Size Status Buyers
Precision BioSciences 28-Mar-2019 IPO 00000 Completed
00000 08-Jan-2019 000000000000000000 00000 Completed
  • 00000 (000000000 0
00000000 000000000 31-Oct-2018 000 00000 Completed
  • 4 buyers
0000000 0000000000 31-Oct-2018 000 00000 Completed
000 00000000 14-Sep-2018 000 00000 Completed
00000 (00000000) 26-Apr-2018 000000000000000000 000.00 Completed
  • 0000000000
0000000 00000000 23-Apr-2018 000 00000 Completed
  • 00000000 000000000
000000 00000000000 09-Apr-2018 000000000000000000 00000 Completed
  • 0&0 000000
Mersana Therapeutics 31-Mar-2018 Secondary Transaction - Open Market Completed
UNUM Therapeutics 29-Mar-2018 IPO 000.00 Completed
To view this investor’s complete exits history, request access »

F-Prime Capital Partners Team (61)

Name Title Deals Funds Boards Office Contact
Info
Mary Pendergast Partner & Chief Financial Officer Cambridge, MA
Carl Byers General Partner 00 0 0 Cambridge, MA
Jay Farber Venture Partner Cambridge, MA
John Vigeant Venture Partner Cambridge, MA
Sanjay Aggarwal Venture Partner 0 Cambridge, MA

16 Former Team Members

You’re viewing 5 of 61 team members. Get the full list »

F-Prime Capital Partners Co-Investors (445)

Name With Exits Lead Partner
Eight Roads 47 0 00
ARCH Venture Partners 0 0
GV 0 0 0
Cormorant Asset Management 0 0 0
OrbiMed 0 0 0
To view this investor’s complete co-investor history, request access »